Hansen Medical launches its re-designed Artisan study, enrolling the initial 5 patients to evaluate robot-assisted catheter surgery for atrial fibrillation.

Hansen Medical (NSDQ:HNSN) enrolled the 1st 5 patients in a re-designed study to evaluate its robot-assisted atrial fibrillation treatment.

The revised study design, which won conditional FDA approval in May, will eventually enroll 125 patients at 14 medical centers to test Hansen’s Sensei X robotic catheter system with the company’s Artisan control catheters.